Abstract
Eight years ago we reviewed the role of bone morphogenetic proteins (BMPs) in articular cartilage repair in the last edition of this series on BMPs. Since that time our understanding of the function of BMPs and especially BMP-7, also called osteogenic protein-1 (OP-1), in cartilage homeostasis and repair has significantly increased. The primary focus of this chapter is the potential therapeutic opportunity for BMPs in the treatment of osteoarthritis. The intervening data confirm that among BMPs, BMP-7 exhibits the most robust evidence supporting its use for cartilage repair and regeneration. In the current review, we continue to unravel more of the underlying mechanisms of the anabolic and anti-catabolic activities of BMPs to provide a better understanding of the interactions between BMPs and signaling pathways and highlight the increased role BMP-7 and other BMPs play in human cartilage homeostasis. In regard to in vivo activities, exciting new data have been published demonstrating that BMP-7, in multiple models of osteoarthritis, can delay or inhibit degradation of the articular cartilage. Most interesting is that for the first time, a clinical trial has been reported, and Phase I data evaluation of the effect of a single injection of BMP-7 into osteoarthritic knees demonstrated enough of a positive response to warrant a Phase II study. Together, recent studies continue to indicate a significant opportunity for BMPs and particularly BMP-7 as therapeutics for osteoarthritis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moran CJ, Pascual-Garrido C, Chubinskaya S, Potter HG, Warren RF, Cole BJ, Rodeo SA (2014) Restoration of articular cartilage. J Bone Joint Surg Am 96:336–344
Pulsatelli L, Addimanda O, Brusi V, Pavloska B, Meliconi R (2013) New findings in osteoarthritis pathogenesis: therapeutic implications. Ther Adv Chronic Dis 4:23–43
Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF (1987) The prevalence of knee osteoarthritis in the elderly. the framingham osteoarthritis study. Arthritis Rheum 30(8):914–918
Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J, Fang F, Schwartz TA, Abbate LM, Callahan LF, Kalsbeek WD, Hochberg MC (2007) Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol 34(1):172–180
Chubinskaya S, Hurtig M, Rueger DC (2008) Bone Morphogen proteins in cartilage biology. In: Vukicevic S, Sampath KT (eds) Bone morphogenetic proteins: from local to systemic theraputics. Birkhauser, Basel, pp. 277–315
Chubinskaya S, Segalite D, Pikovsky D, Hakimiyan AA, Rueger DC (2007) Effects induced by BMPS in cultures of human articular chondrocytes: comparative studies. Growth Factors 26:275–283
van der Kraan PM, Blaney Davidson EN, van den Berg WB (2010) Bone morphogenetic proteins and articular cartilage: to serve and protect or a wolf in sheep clothing's? Osteoarthritis Cartilage 18(6):735–741
Kemmis CM, Vahdati A, Weiss HE, Wagner DR (2010) Bone morphogenetic protein 6 drives both osteogenesis and chondrogenesis in murine adipose-derived mesenchymal cells depending on culture conditions. Biochem Biophys Res Commun 401(1):20–25
Chubinskaya S, Hurtig M, Rueger DC (2007) OP-1/BMP-7 in cartilage repair. Int Orthop 31(6):773–781
Miyamoto C, Matsumoto T, Sakimura K, Shindo H (2007) Osteogenic protein-1 with transforming growth factor-beta1: potent inducer of chondrogenesis of synovial mesenchymal stem cells in vitro. J Orthop Sci 12(6):555–561
Shen B, Wei A, Whittaker S, Williams LA, Tao H, Ma DD, Diwan AD (2010) The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. J Cell Biochem 109(2):406–416
Chubinskaya S, Otten L, Soeder S, Borgia JA, Aigner T, Rueger DC, Loeser RF (2011) Regulation of chondrocyte gene expression by osteogenic protein-1. Arthritis Res Ther 13(2):R55
Chubinskaya S, Hakimiyan A, Pacione C, Yanke A, Rappoport L, Aigner T, Rueger DC, Loeser RF (2007) Synergistic effect of IGF-1 and OP-1 on matrix formation by normal and OA chondrocytes cultured in alginate beads. Osteoarthritis Cartilage 15(4):421–430
Nishida Y, Knudson CB, Eger W, Kuettner KE, Knudson W (2000) Osteogenic protein 7 stimulates cells-associated matrix assembly by normal human articular chondrocytes: up-regulation of hyaluronan synthase, CD44, and aggrecan. Arthritis Rheum 43(1):206–214
Vinall RL, Lo SH, Reddi AH (2002) Regulation of articular chondrocyte phenotype by bone morphogenetic protein 7, interleukin 1, and cellular context is dependent on the cytoskeleton. Exp Cell Res 272:32–44
Loeser RF, Gandhi U, Long DL, Yin W, Chubinskaya S (2014) Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1. Arthritis Rheumatol 66(8):2201–2209
Bobinac D, Spanjol J, Marinović M, Zoricić Cvek S, Marić I, Cicvarić T, Fuckar D, Markić D, Vojniković B (2008) Expression of bone morphogenetic proteins, cartilage-derived morphogenetic proteins and related receptors in normal and osteoarthritic human articular cartilage. Coll Antropol 32(Suppl 2):83–87
Bobacz K, Gruber R, Soleiman A, Erlacher L, Smolen JS, Graninger WB (2003) Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. Arthritis Rheum 48(9):2501–2508
Schmal H, Mehlhorn AT, Pilz IH, Dovi-Akue D, Kirchhoff C, Südkamp NP, Gerlach U, Lohrmann C, Niemeyer P (2012) Immunohistological localization of BMP-2, BMP-7, and their receptors in knee joints with focal cartilage lesions. Scientific World Journal 2012:467892
Schmal H, Niemeyer P, Zwingmann J, Stoffel F, Südkamp NP, Mehlhorn AT (2010) Association between expression of the bone morphogenetic. proteins 2 and 7 in the repair of circumscribed cartilage lesions with clinical outcome. BMC Musculoskelet Disord 11:170
Loeser RF, Im HJ, Richardson B, Lu Q, Chubinskaya S (2009) Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis Cartilage 17(4):513–517
Soeder S, Hakimiyan A, Rueger D, Kuettner KE, Aigner T, Chubinskaya S (2005) Antisense inhibition of osteogenic protein-1 disturbs human articular cartilage integrity. Arthritis Rheum 52(2):468–478
Dudley A, Lyons K, Robertson E (1995) A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795–2807
Luo G, Hofmann C, Bronckers A, Sohock M, Bradley A et al (1995) BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808–2820
Tsuji K, Cox K, Gamer L, Graf D, Economides A, Rosen V (2010) Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair. J Orthop Res 28:384–389
Abula K, Muneta T, Miyatake K, Yamada J, Matsukura Y, Inoue M, Sekiya I, Graf D, Economides AN, Rosen V, Tsuji K (2015) Elimination of BMP7 from the developing limb mesenchyme leads to articular cartilage degeneration and synovial inflammation with increased age. FEBS Lett 589(11):1240–1248
Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V (2006) BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38(12):1424–1429
Hurtig M, Chubinskaya S, Dickey J, Rueger D (2009) BMP-7 protects against progression of cartilage degeneration after impact injury. J Orthop Res 27(5):602–611
Badlani N, Inoue A, Healey R, Coutts R, Amiel D (2008) The protective effect of OP-1 on articular cartilage in the development of osteoarthritis. Osteoarthritis Cartilage 16(5):600–606
Badlani N, Oshima Y, Healey R, Coutts R, Amiel D (2009) Use of bone morphogenic protein-7 as a treatment for osteoarthritis. Clin Orthop Relat Res 467(12):3221–3229
Sekiya I, Tang T, Hayashi M, Morito T, Ju YJ, Mochizuki T, Muneta T (2009) Periodic knee injections of BMP-7 delay cartilage degeneration induced by excessive running in rats. J Orthop Res 27(8):1088–1092
Hayashi M, Muneta T, Takahashi T, Ju YJ, Tsuji K, Sekiya I (2010) Intra-articular injections of bone morphogenetic protein-7 retard progression of existing cartilage degeneration. J Orthop Res 28(11):1502–1506
Bolam C, Hurtig M, Cruz A, McEwen B (2006) Characterization of a model of post-traumatic osteoarthritis in the equine femorotibial joint. Am J Vet Res 67(3):433–447
Hunter DJ, Pike MC, Jonas BL, Kissin E, Krop J, McAlindon T (2010) Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis. BMC Musculoskelet Disord 11:232
Anderson DD, Chubinskaya S, Guilak F, Martin JA, Oegema TR, Olson SA, Buckwalter JA (2011) Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J Orthop Res 29:802–809
Sakata R, Iwakura T, Reddi AH (2015) Regeneration of articular cartilage surface: morphogens, cells, and extracellular matrix scaffolds. Tissue Eng Part B 21:461–473
Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ (2011) The role of growth factors in cartilage repair. Clin Orthop Relat Res 469:2706–2715
Lohmander LS, Hellot S, Dreher D, Krantz EF, Kruger DS, Guermazi A, Eckstein F (2014) Intraarticular spifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol 66:1820–1831
Ali IH, Brazil DP (2014) Bone morphogenetic proteins and their antagonists: current and emerging clinical uses. Br J Pharmacol 171(15):3620–3632
Tardif G, Pelletier JP, Boileau C, Martel-Pelletier J (2009) The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: an immunohistochemical study. Osteoarthritis Cartilage 17:263–270
Ciuclan L, Sheppard K, Dong L, Sutton D, Duggan N, Hussey M et al (2013) Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice. Am J Pathol 183:1461–1473
Lepparanta O, Tikkanen JM, Bespalov MM, Kali K, Myllarniemi M (2013) Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo. Am J Respir Cell Mol Biol 48:448–455
Sugimoto H, LeBleu VS, Bosukonda D, Keck P, Taduri G, Bechtel W et al (2012) Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med 18:396–404
Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA et al (2008b) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4:33–41
Sanvitale CE, Kerr G, Chaikuad A, Ramel MC, Mohedas AH, Reichert S et al (2013) A new class of small molecule inhibitor of BMP signaling. PLoS One 8:e62721
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Chubinskaya, S., Rueger, D.C. (2017). BMP Signaling in Articular Cartilage Repair and Regeneration: Potential Therapeutic Opportunity for Osteoarthritis. In: Vukicevic, S., Sampath, K. (eds) Bone Morphogenetic Proteins: Systems Biology Regulators. Progress in Inflammation Research. Springer, Cham. https://doi.org/10.1007/978-3-319-47507-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-47507-3_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47505-9
Online ISBN: 978-3-319-47507-3
eBook Packages: MedicineMedicine (R0)